S
AIMT

SignatureFD’s Aimmune Therapeutics AIMT Stock Holding History

SignatureFD’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-28
Closed -$1K – 2798
2020
Q3 		$1K Buy
+28
New +$596 ﹤0.01% 2562
2020
Q2 		– Sell
-1
Closed – – 2746
2020
Q1 		$0 Hold
1
– – ﹤0.01% 2549
2019
Q4 		$0 Hold
1
– – ﹤0.01% 2342
2019
Q3 		$0 Hold
1
– – ﹤0.01% 2265
2019
Q2 		$0 Buy
+1
New +$21 ﹤0.01% 2225

SignatureFD's AIMT Position: Q4 2020 in Review

SignatureFD sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 28 shares — an estimated $1K sold.

SignatureFD first reported a position in AIMT in Q2 2019 and held it in 5 quarters. The position peaked at $1K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • SignatureFD reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • SignatureFD sold 28 Aimmune Therapeutics shares in Q4 2020, an estimated $1K.
  • SignatureFD first reported a position in Aimmune Therapeutics in Q2 2019 and held it in 5 quarters.
  • SignatureFD's Aimmune Therapeutics position peaked at $1K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on SignatureFD's 13F filing for Q4 2020, filed 11 Feb 2021.